Dahlberg S, Chang E, Weiss S, Dopart P, Gould E, Ritchey M
Diabetes Metab Syndr Obes. 2022; 15:3049-3067.
PMID: 36200062
PMC: 9529009.
DOI: 10.2147/DMSO.S381652.
Havard A, Choi S, Pearson S, Chow C, Tran D, Filion K
JAMA Netw Open. 2021; 4(11):e2136372.
PMID: 34842922
PMC: 8630569.
DOI: 10.1001/jamanetworkopen.2021.36372.
DArcy M, Sturmer T, Lund J
Curr Epidemiol Rep. 2019; 5(3):272-283.
PMID: 30666285
PMC: 6338470.
DOI: 10.1007/s40471-018-0155-y.
Roumie C, Patel N, Munoz D, Bachmann J, Stahl A, Case R
Contemp Clin Trials Commun. 2018; 10:42-49.
PMID: 29696157
PMC: 5898539.
DOI: 10.1016/j.conctc.2018.03.001.
Mladenka P, Applova L, Patocka J, Costa V, Remiao F, Pourova J
Med Res Rev. 2018; 38(4):1332-1403.
PMID: 29315692
PMC: 6033155.
DOI: 10.1002/med.21476.
A proposed approach to accelerate evidence generation for genomic-based technologies in the context of a learning health system.
Lu C, Williams M, Ginsburg G, Toh S, Brown J, Khoury M
Genet Med. 2017; 20(4):390-396.
PMID: 28796238
DOI: 10.1038/gim.2017.122.
Priorities for Cardiovascular Outcomes Research: A Report of the National Heart, Lung, and Blood Institute's Centers for Cardiovascular Outcomes Research Working Group.
Khazanie P, Krumholz H, Kiefe C, Kressin N, Wells B, Wang T
Circ Cardiovasc Qual Outcomes. 2017; 10(7).
PMID: 28710296
PMC: 7811766.
DOI: 10.1161/CIRCOUTCOMES.115.001967.
Clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods.
Richesson R, Sun J, Pathak J, Kho A, Denny J
Artif Intell Med. 2016; 71:57-61.
PMID: 27506131
PMC: 5480212.
DOI: 10.1016/j.artmed.2016.05.005.
Varenicline and Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Sterling L, Windle S, Filion K, Touma L, Eisenberg M
J Am Heart Assoc. 2016; 5(2).
PMID: 26903004
PMC: 4802486.
DOI: 10.1161/JAHA.115.002849.
Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.
Wang S, Verpillat P, Rassen J, Patrick A, Garry E, Bartels D
Clin Pharmacol Ther. 2015; 99(3):325-32.
PMID: 26690726
PMC: 7833029.
DOI: 10.1002/cpt.329.
Evaluation of the cardiovascular effects of varenicline in rats.
Selcuk E, Sungu M, Parlakpinar H, Ermis N, Taslidere E, Vardi N
Drug Des Devel Ther. 2015; 9:5705-17.
PMID: 26543352
PMC: 4622455.
DOI: 10.2147/DDDT.S92268.
Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study.
Kotz D, Viechtbauer W, Simpson C, van Schayck O, West R, Sheikh A
Lancet Respir Med. 2015; 3(10):761-8.
PMID: 26355008
PMC: 4593936.
DOI: 10.1016/S2213-2600(15)00320-3.
Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review.
Bazelier M, Eriksson I, de Vries F, Schmidt M, Raitanen J, Haukka J
Pharmacoepidemiol Drug Saf. 2015; 24(9):897-905.
PMID: 26175179
PMC: 5034829.
DOI: 10.1002/pds.3828.
A system to build distributed multivariate models and manage disparate data sharing policies: implementation in the scalable national network for effectiveness research.
Meeker D, Jiang X, Matheny M, Farcas C, DArcy M, Pearlman L
J Am Med Inform Assoc. 2015; 22(6):1187-95.
PMID: 26142423
PMC: 4639714.
DOI: 10.1093/jamia/ocv017.
Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.
Sharma A, Thakar S, Lavie C, Garg J, Krishnamoorthy P, Sochor O
Curr Cardiol Rep. 2014; 17(1):554.
PMID: 25410148
DOI: 10.1007/s11886-014-0554-8.
A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment.
Gagne J, Wang S, Rassen J, Schneeweiss S
Pharmacoepidemiol Drug Saf. 2014; 23(6):619-27.
PMID: 24788694
PMC: 4159708.
DOI: 10.1002/pds.3616.
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.
Mills E, Thorlund K, Eapen S, Wu P, Prochaska J
Circulation. 2013; 129(1):28-41.
PMID: 24323793
PMC: 4258065.
DOI: 10.1161/CIRCULATIONAHA.113.003961.
